Cancer Gene Therapy - Table of Contents alert Volume 25 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 25, Issue 1 In this issue Article Also new AOP   Article Downregulation of liver–intestine cadherin enhances cisplatin-induced apoptosis in human gastric cancer BGC823 cells Meng Liu, Zheng Han, Qing-Xi Zhu, Jie Tan, Wei-Jie Liu et al. Cancer Gene Therapy 2017 25 :1 - 9; December 04, 2017; 10.1038/s41417-017-0001-2   Abstract | Full Text LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer Xianxiang Cao, Jing Xu & Dong Yue Cancer Gene Therapy 2017 25 :10 - 17; December 12, 2017; 10.1038/s41417-017-0006-x   Abstract | Full Text Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction Xiaofei Zhang, Ping Cui, Beichen Ding, Yuening Guo, Kaiyu Han et al. Cancer Gene Therapy 2017 25 :18 - 26; December 12, 2017; 10.1038/s41417-017-0008-8   Abstract | Full Text Development of an adenovirus vector vaccine platform for targeting dendritic cells Piyush K. Sharma, Igor P. Dmitriev, Elena A. Kashentseva, Geert Raes, Lijin Li et al. Cancer Gene Therapy 2017 25 :27 - 38; December 15, 2017; 10.1038/s41417-017-0002-1   Abstract | Full Text LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer Haoyu Zhou, Zhihua Sun, Songwei Li, Xiaofeng Wang & Xuejun Zhou Cancer Gene Therapy 2017 25 :39 - 46; December 12, 2017; 10.1038/s41417-017-0003-0   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.